- Report
- August 2022
- 120 Pages
Global
From €4072EUR$4,500USD£3,478GBP
- Drug Pipelines
- April 2025
- 180 Pages
Global
From €2262EUR$2,500USD£1,932GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1810EUR$2,000USD£1,546GBP
- Report
- December 2024
- 30 Pages
Global
From €2488EUR$2,750USD£2,126GBP
- Report
- December 2024
- 30 Pages
Global
From €2488EUR$2,750USD£2,126GBP
- Report
- July 2024
- 150 Pages
Global
From €3393EUR$3,750USD£2,899GBP
- Report
- December 2024
- 152 Pages
Global
From €3574EUR$3,950USD£3,053GBP
- Report
- December 2024
- 30 Pages
Global
From €2488EUR$2,750USD£2,126GBP
- Report
- June 2024
- 200 Pages
Global
From €7194EUR$7,950USD£6,145GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2524EUR$2,789USD£2,156GBP
- Report
- April 2023
- 160 Pages
Global
From €4478EUR$4,949USD£3,825GBP
- Report
- April 2023
- 115 Pages
Global
From €4298EUR$4,750USD£3,671GBP
- Report
- April 2023
- 116 Pages
Global
From €4072EUR$4,500USD£3,478GBP
- Report
- May 2025
- 196 Pages
Global
From €4298EUR$4,750USD£3,671GBP
- Report
- February 2024
- 110 Pages
Global
From €4298EUR$4,750USD£3,671GBP
- Report
- December 2024
- 70 Pages
Global
From €3615EUR$3,995USD£3,088GBP
- Report
- October 2022
- 81 Pages
Global
From €3163EUR$3,495USD£2,701GBP
- Report
- February 2025
- 135 Pages
Global
From €16284EUR$17,995USD£13,909GBP
- Report
- January 2025
- 105 Pages
Global
From €3500EUR$4,143USD£3,094GBP
- Report
- August 2024
- 133 Pages
China
From €1629EUR$1,800USD£1,391GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more